(Q42437041)

31 October 2017

Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer (English)

1 reference

31 October 2017

0 references

1 reference

1 reference

1 reference

2

1 reference

31 October 2017

Susanne Müerköster

1

1 reference

31 October 2017

Maike Witt

3

1 reference

31 October 2017

André Gehrz

4

1 reference

31 October 2017

Sieglinde Haye

5

1 reference

31 October 2017

Christina March

6

1 reference

31 October 2017

Frauke Grohmann

7

1 reference

31 October 2017

Kai Wegehenkel

8

1 reference

31 October 2017

Holger Kalthoff

9

1 reference

31 October 2017

Ulrich R Fölsch

10

1 reference

31 October 2017

Heiner Schäfer

11

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

International Journal of Cancer

31 October 2017

1 reference

31 October 2017

104

1 reference

31 October 2017

469-476

1 reference

31 October 2017

4

1 reference

31 October 2017

Cancer statistics, 1997.

1 reference

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

21 January 2018

1 reference

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

21 January 2018

1 reference

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect

21 January 2018

1 reference

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

21 January 2018

1 reference

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand

21 January 2018

1 reference

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

21 January 2018

1 reference

NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases

21 January 2018

1 reference

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons

21 January 2018

1 reference

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

21 January 2018

1 reference

Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription.

21 January 2018

1 reference

21 January 2018

1 reference

Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study

21 January 2018

1 reference

Treatment of advanced and metastatic pancreatic cancer

21 January 2018

1 reference

Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates

21 January 2018

1 reference

Distinct pathways for stimulation of cytochrome c release by etoposide

21 January 2018

1 reference

Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10963

1 reference

31 October 2017

1 reference